tiprankstipranks
Travere Therapeutics (TVTX)
NASDAQ:TVTX

Travere Therapeutics (TVTX) Financial Statements

304 Followers

Travere Therapeutics Financial Overview

Travere Therapeutics's market cap is currently ―. The company's EPS TTM is $-4.558; its P/E ratio is -1.64; Travere Therapeutics is scheduled to report earnings on May 2, 2024, and the estimated EPS forecast is $-0.95. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ -8.55M$ 37.09M$ 57.01M$ 56.99M$ 55.87M
Gross Profit$ -16.61M$ 35.81M$ 59.55M$ 45.11M$ 56.30M
EBIT$ -112.36M$ -86.43M$ -82.67M$ -86.96M$ -65.98M
EBITDA$ -103.43M-$ -72.09M$ -77.41M$ -56.25M
Net Income Common Stockholders$ -90.17M$ -89.24M$ -85.63M$ -86.33M$ -69.91M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 566.85M$ 634.64M$ 491.34M$ 561.51M$ 450.25M
Total Assets$ 788.91M$ 832.85M$ 736.43M$ 808.23M$ 672.59M
Total Debt$ 404.78M$ 405.48M$ 406.17M$ 406.85M$ 407.49M
Net Debt$ -162.07M$ -229.16M$ -85.17M$ -154.67M$ -42.76M
Total Liabilities$ 588.10M$ 553.08M$ 619.94M$ 619.09M$ 629.73M
Stockholders Equity$ 200.81M$ 279.77M$ 116.48M$ 189.14M$ 42.85M
Cash Flow-
Free Cash Flow$ -76.00M-$ -72.50M$ -109.08M$ -58.84M
Operating Cash Flow$ -70.47M$ -59.13M$ -69.30M$ -81.12M$ -54.64M
Investing Cash Flow$ -16.95M$ 133.32M$ -23.55M$ -37.04M$ -36.70M
Financing Cash Flow$ 124.00K$ -634.00K$ 2.27M$ 217.00M$ 551.00K
Currency in USD

Travere Therapeutics Earnings and Revenue History

Travere Therapeutics Debt to Assets

Travere Therapeutics Cash Flow

Travere Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis